Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone

  • Rosanna Iacona | rosanna.iacona@virgilio.it Chair and Division of Cardiology, University Hospital “Paolo Giaccone”, Palermo, Italy.
  • Vito Bonomo Chair and Division of Cardiology, University Hospital “Paolo Giaccone”, Palermo, Italy.
  • Mariaconcetta Di Piazza Chair and Division of Cardiology, University Hospital “Paolo Giaccone”, Palermo, Italy.
  • Angela Sansone Chair and Division of Cardiology, University Hospital “Paolo Giaccone”, Palermo, Italy.
  • Manuela Usala Orthopedic Institute Rizzoli, Department of Sicily Region (DRS), Bologna, Italy, Italy.
  • Salvatore Novo Chair and Division of Cardiology, University Hospital “Paolo Giaccone”, Palermo, Italy.
  • Carlo Pavone Chair and Division of Urology, University Hospital “Paolo Giaccone”, Palermo, Italy.

Abstract

Objective: Testosterone levels play a role in cardiac and vascular pathology. In the present study we investigated the prognostic significance of this hormone for cardiovascular outcome, in a 5-year follow-up. Materials and methods: Our cohort included 802 adult subjects, from 40 to 80 years. Patients were excluded if they had a past history of peripheral or coronary artery disease, and revascularization. A blood sample was drawn to valuate testosterone level, and we considered normal testosterone levels 300 ng/dl. FMD (flow mediated dilatation) of the brachial artery was assessed by measuring the increase of the brachial artery diameter during reactive hyperemia after transient forearm ischemia. B-mode longitudinal images of the brachial artery were obtained at the level of the antecubital fossa. The FMD was defined as the percentage change in the brachial artery diameter 60 s after releasing the ischemic cuff. Erectile dysfunction (ERD) was assessed by the International Index of Erectile Function-5 (IIEF-5) score questionnaire. We considered composite end points including the following major adverse cardiovascular events (MACEs) Results: Subjects with lower serum testosterone levels (n = 332) had higher prevalence of traditional cardiovascular risk factors, such as hypertension (p = 0.009), diabetes (p = 0.03), dyslipidemia (p < 0.0001), obesity (p = 0.002), and endothelial function score (p < 0.0001). AMI, death after AMI, major stroke and all clinical events were more frequent (p < 0.001) in patients with testosterone levels < 300 ng/dl. Further, by multiple logistic regression analysis we found that only dyslipidemia (p = 0,001), obesity (p = 0,007), testosterone < 300 ng/dl (p < 0,0001) and ED (p < 0,0001) were independent predictors of future events. Conclusions: A therapeutic intervention on testosterone may not only have a positive effect on the cardiovascular system but also an important role in preventing new cardiovascular events.

Downloads

Download data is not yet available.

PUBLICATION METRICS

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Dimensions

Altmetric

Published
2017-12-31
Info
Issue
Section
Original Papers - Andrology
Keywords:
Erectile dysfunction, Cardiovascular events, Prevention
Statistics
  • Abstract views: 982

  • PDF: 449
How to Cite
Iacona, R., Bonomo, V., Di Piazza, M., Sansone, A., Usala, M., Novo, S., & Pavone, C. (2017). Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone. Archivio Italiano Di Urologia E Andrologia, 89(4), 313-315. https://doi.org/10.4081/aiua.2017.4.313